Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Hepatitis E vaccine: not a moment too soon.

Holmberg SD.

Lancet. 2010 Sep 11;376(9744):849-51. doi: 10.1016/S0140-6736(10)61260-3. Epub 2010 Aug 20. No abstract available.

PMID:
20728933
2.

Hepatitis E vaccine: why wait?

[No authors listed]

Lancet. 2010 Sep 11;376(9744):845. doi: 10.1016/S0140-6736(10)61393-1. No abstract available.

PMID:
20833284
3.

Subduing the hepatitis E Python.

Teo CG.

Epidemiol Infect. 2009 Apr;137(4):480-4. doi: 10.1017/S0950268808001295. Epub 2008 Sep 17. No abstract available.

PMID:
18796176
4.

Perspectives of vaccination against hepatitis E.

Safary A.

Intervirology. 2001;44(2-3):162-6.

PMID:
11509877
5.

Hepatitis E vaccine: WHO position paper, May 2015.

[No authors listed]

Wkly Epidemiol Rec. 2015 May 1;90(18):185-200. English, French. No abstract available.

6.

Recombinant vaccines for hepatitis E.

Emerson SU, Purcell RH.

Trends Mol Med. 2001 Oct;7(10):462-6. Review.

PMID:
11597521
7.

Hepatitis E: a neglected threat.

Myint KS, Gibbons RV.

Trans R Soc Trop Med Hyg. 2008 Mar;102(3):211-2. Epub 2007 Jul 20. Review.

PMID:
17658568
8.

Hepatitis E: a puzzling double-faced disease.

RomanĂ² L, Paladini S, Zanetti AR.

Ann Ig. 2013 May-Jun;25(3):169-80. doi: 10.7416/ai.2013.1919.

PMID:
23598800
9.

Hepatitis: Hepatitis E vaccination--is HEV 239 the breakthrough?

Wedemeyer H, Pischke S.

Nat Rev Gastroenterol Hepatol. 2011 Jan;8(1):8-10. doi: 10.1038/nrgastro.2010.207. No abstract available.

PMID:
21212772
10.

Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity.

Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, Yao X, Liang ZL, Wu T, Li JX, Yan Q, Yang CL, Jiang HM, Huang HJ, Xian YL, Shih JW, Ng MH, Li YM, Wang JZ, Zhu FC, Xia NS.

Clin Microbiol Infect. 2014 Jun;20(6):O397-405. doi: 10.1111/1469-0691.12419. Epub 2013 Nov 18.

11.

Toward the development of a hepatitis E vaccine.

Kamili S.

Virus Res. 2011 Oct;161(1):93-100. doi: 10.1016/j.virusres.2011.05.008. Epub 2011 May 18. Review.

PMID:
21620908
12.

Hepatitis E, a vaccine-preventable cause of maternal deaths.

Labrique AB, Sikder SS, Krain LJ, West KP Jr, Christian P, Rashid M, Nelson KE.

Emerg Infect Dis. 2012 Sep;18(9):1401-4. doi: 10.3201/eid1809.120241. Review.

13.

U.S. Military sponsored vaccine trials and la resistance in Nepal.

Andrews J.

Am J Bioeth. 2005 Summer;5(3):W1-3. No abstract available.

PMID:
16006352
14.

Lessons from hepatitis E vaccine design.

Li S, Zhang J, Xia N.

Curr Opin Virol. 2015 Apr;11:130-6. doi: 10.1016/j.coviro.2015.04.003. Epub 2015 Apr 22. Review.

PMID:
25913817
15.

Epidemiology of hepatitis E: current status.

Aggarwal R, Naik S.

J Gastroenterol Hepatol. 2009 Sep;24(9):1484-93. doi: 10.1111/j.1440-1746.2009.05933.x. Epub 2009 Aug 3. Review.

PMID:
19686410
16.

Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine.

Purcell RH, Nguyen H, Shapiro M, Engle RE, Govindarajan S, Blackwelder WC, Wong DC, Prieels JP, Emerson SU.

Vaccine. 2003 Jun 2;21(19-20):2607-15.

PMID:
12744897
17.

Hepatitis E vaccine development: a 14 year odyssey.

Wu T, Li SW, Zhang J, Ng MH, Xia NS, Zhao Q.

Hum Vaccin Immunother. 2012 Jun;8(6):823-7. doi: 10.4161/hv.20042. Epub 2012 Jun 1.

PMID:
22699438
18.

Trial watch: hepatitis E vaccine confers complete protection in phase III trial.

[No authors listed]

Nat Rev Drug Discov. 2010 Oct;9(10):754. doi: 10.1038/nrd3285. No abstract available.

PMID:
20885397
19.

[Hepatitis E: an emerging viral disease].

Soriano V, Barreiro P.

Med Clin (Barc). 2014 Jul 7;143(1):22-4. doi: 10.1016/j.medcli.2014.01.021. Epub 2014 Mar 20. Spanish. No abstract available.

PMID:
24656852
20.

Hepatitis E vaccines: progress and prospects.

Worm HC, Wirnsberger G.

Drugs. 2004;64(14):1517-31. Review.

PMID:
15233590

Supplemental Content

Support Center